Most engineers first run into ASTM A967 during an audit or a customer qualification, not in a classroom. Someone from QA asks for passivation records, an inspector flags a gap in the documentation, and suddenly the spec number matters. Published by ASTM International, this specification governs how stainless steel parts get chemically passivated. It spells out 10 methods (split between nitric and citric acid) and 7 acceptance tests that confirm the treatment removed free iron from the surface.
The current edition, A967/A967M-25, was approved on January 1, 2025 and went live on January 24 of the same year. Whether your team passivates pharmaceutical reactors in Hyderabad, food processing vessels in Pune, or pipe spools at a fabrication shop in Vadodara, this is the spec your QA binder should reference.
In brief: ASTM A967/A967M is the governing specification for chemical passivation of stainless steel parts. It includes 5 nitric acid methods (Nitric 1 through 5) and 5 citric acid methods (Citric 1 through 5), each with defined concentration, temperature, and time parameters. Rouging Solutions Pvt. Ltd., headquartered in Ahmedabad, performs citric acid passivation under this standard for pharmaceutical, semiconductor, and food processing facilities across India.
According to ASTM International, its full title is "Standard Specification for Chemical Passivation Treatments for Stainless Steel Parts." The scope covers three treatment types: nitric acid immersion, citric acid immersion, and electrochemical treatment.
But the spec goes beyond just the passivation step. It also addresses descaling, cleaning, and surface preparation before treatment begins, which is where a surprising number of process failures start. Grinding debris left on a weld, a thin oil film from handling, heat tint from a poorly shielded heat-affected zone: any of these will prevent a proper passive layer from forming, no matter which chemistry you pick.
The specification applies to wrought, cast, and powder metallurgy stainless steels. Method selection depends on the alloy grade. A 300-series austenitic steel like 316L (the workhorse in pharma equipment) behaves differently during treatment than a 400-series martensitic grade used in tooling or turbine components.
Back in 1963, the U.S. Department of Defense published QQ-P-35. That spec defined eight passivation processes, every one of them based on nitric acid. For the next three decades, it was the only game in town if you needed a recognized standard for passivation work.
Then came the National Technology Transfer and Advancement Act (NTTAA) of 1995. The law pushed federal agencies to adopt private-sector standards instead of maintaining separate military specs. ASTM responded by publishing A967-96 on September 10, 1996. QQ-P-35C was cancelled on 11 September 1998 by Notice 3, which superseded Notice 2 of 14 November 1997.
What made A967 more than a repackaging job? Citric acid. The new standard introduced it as an approved passivation chemistry, something QQ-P-35 never permitted. That single addition gave facilities a path toward safer, non-toxic treatment without sacrificing spec compliance. For a side-by-side breakdown of both chemistries, see our post on citric acid vs nitric acid passivation.
The spec lays out five nitric acid methods and five citric acid methods, each with its own concentration range, temperature window, and minimum immersion time. Three of the ten (Nitric 5, Citric 4, Citric 5) are open-ended: you can develop a custom process, provided the treated parts pass the acceptance tests.
| Method | Concentration | Temperature | Min. Time | Notes |
|---|---|---|---|---|
| Nitric 1 | 20-25% v/v HNO₃ + 2.5% w/w sodium dichromate | 49-54°C | 20 min | Contains hexavalent chromium; restricted under EU REACH |
| Nitric 2 | 20-45% v/v HNO₃ | 21-32°C | 30 min | Room temperature process |
| Nitric 3 | 20-25% v/v HNO₃ | 49-60°C | 20 min | Mid-range temperature, no dichromate |
| Nitric 4 | 45-55% v/v HNO₃ | 49-54°C | 30 min | Highest concentration |
| Method | Concentration | Temperature | Min. Time | Notes |
|---|---|---|---|---|
| Citric 1 | 4-10% w/w | 60-71°C | 4 min | Shortest cycle in the entire standard |
| Citric 2 | 4-10% w/w | 49-60°C | 10 min | Mid-range |
| Citric 3 | 4-10% w/w | 21-49°C | 20 min | Room to warm temperature |
Notice that Citric 1 needs just 4 minutes at 60-71°C. That's the fastest defined method in the entire spec. For a facility running passivation on production batches, shaving 26 minutes off each cycle compared to Nitric 2 adds up when you're processing hundreds of fittings or pipe spools per week.
Passivation is only half the job. You also have to prove the treatment worked, and that's where Practices A through G come in. The standard offers seven verification tests, and the one your facility uses depends on what the customer or regulator specifies.
| Practice | Test | What It Checks |
|---|---|---|
| A | Water Immersion | Parts soaked in deionized water; rust stains indicate failure |
| B | High Humidity | Exposure to humid conditions reveals incomplete passivation |
| C | Salt Spray | 5% NaCl spray per ASTM B117; white salt deposits pass, rust fails |
| D | Copper Sulfate | Acidified CuSO₄ applied for 6 minutes; copper-colored deposits indicate free iron |
| E | Potassium Ferricyanide | Chemical detection of free iron on the surface |
| F | Damp Cloth | Contact test for surface contamination |
| G | Boiling Water | Immersion in boiling water as a corrosion indicator |
In pharma and food processing, Practice D (copper sulfate) and Practice E (ferricyanide) are the ones you'll see called out most often. They catch free iron directly rather than waiting hours or days for visible corrosion to show up.
To illustrate: imagine a batch of 316L fittings arrives at your Ahmedabad facility after third-party passivation. A Practice D test takes 6 minutes per piece. If the surface turns copper-colored, you've got free iron, and those fittings aren't going into a WFI loop until they're retreated.
Here's what trips people up: the FDA never actually names this standard in its regulations. The regulatory hook is 21 CFR 211.65, which requires equipment surfaces contacting drug products to be non-reactive, non-additive, and non-absorptive.
That regulation tells you what your surfaces need to be. It doesn't say how to get there. ASME BPE (Bioprocessing Equipment) fills that gap. Its Nonmandatory Appendix E recommends a minimum Cr:Fe ratio of 1.3:1 on the passive layer and points to A967 methods as the way to hit that target (ASME BPE).
In practice, the chain looks like this: 21 CFR 211.65 sets the performance bar, ASME BPE translates it into a measurable number, and A967 gives you the recipe and the tests. When a USFDA inspector pulls your passivation records during a Q1 facility audit, that documented chain is what they want to see. For more on how rouge contamination creates FDA risk, see our earlier post.
A967 doesn't sit alone. A few related standards cover overlapping ground, and confusing them in an SOP or during an audit can create real problems.
| Standard | Scope | When You'd Reference It |
|---|---|---|
| ASTM A380 | The practice for cleaning, descaling, pickling and passivation | Read with A967, for the method and for checking the surface |
| AMS 2700 | Passivation for aerospace applications | Defense and aerospace work; replaced AMS-QQ-P-35 in 2004 |
| ASTM F86 | Surface prep of metallic surgical implants | Medical device industry; stainless passivation normally specified to A967 |
| ASME BPE | Bioprocessing equipment for pharma | Pharma systems; specifies Cr:Fe targets and Ra finish values |
A380 and A967 are meant to work as a pair, though not as two halves of a timeline. A380 is a practice, so it recommends how the cleaning, descaling, pickling and passivation should be done. A967 is a specification, so it sets the treatments and the tests a lot has to pass. If your SOP references one but skips the other, an auditor will spot the gap. Our guide to ASTM A380 covers the practice on its own terms.
Your alloy grade, regulatory context, and existing safety setup all factor into the decision, but they don't carry equal weight at every facility.
Pharma and food processing plants using 316L stainless steel will find that Citric 1 or Citric 2 covers most of what they need. Temperatures stay in the 49-71°C range (a standard heated tank handles that), concentrations at 4-10% by weight are low-hazard, and citric acid carries an FDA GRAS rating. CitriSurf 77 Plus is formulated to operate within these parameters.
Nitric acid still has its place. If a customer spec calls it out by name, or if your parts carry heavy embedded iron from grinding and welding, Nitric 2 or Nitric 3 is where you'd start. Just keep in mind that a nitric setup means fume extraction, acid-resistant containment, and full chemical PPE for every operator near the tank.
Throughput is the other variable that often tips the scale. A fabrication shop processing pipe spools at volume sees a real difference between Citric 1 at 4 minutes and Nitric 2 at 30. Multiply that gap by a week's output and it stops being a minor detail.
What makes A967 useful isn't just the method tables or the test procedures. It's the fact that one document ties together chemistry, process parameters, and verification into a single auditable framework. The A967/A967M-25 edition, now nearly three decades into the standard's evolution, reflects the most current industry agreement on passivation science.
If your facility needs support with method selection or acceptance testing, reach out to our team. With 60+ combined years across pharma, semiconductor, and food processing, we help plant teams put together programs that hold up when inspectors come through.
It's ASTM International's standard specification for chemical passivation of stainless steel parts (full designation: A967/A967M). Inside it you'll find 10 methods covering both nitric and citric acid chemistry, plus 7 acceptance tests that verify free iron removal. The edition currently in force is A967/A967M-25, published January 2025.
Yes, and it has since the very first edition in 1996. Five citric acid methods (Citric 1 through 5) carry the same formal weight as the five nitric acid methods. Before A967, the older military spec QQ-P-35 only permitted nitric acid. That limitation was one of the reasons the industry pushed for a civilian replacement.
Not by name. The FDA's 21 CFR 211.65 requires pharmaceutical equipment surfaces to be non-reactive, but it doesn't point to any specific passivation standard. ASME BPE acts as the bridge: it sets a minimum Cr:Fe ratio of 1.3:1 for bioprocessing equipment and references A967 methods as the way to meet that target.
They answer different questions. A380 is a practice. Its title runs cleaning, descaling, pickling and passivation, so it deals with how the work is carried out. A967 is the specification behind it, setting the chemical treatments and the tests that decide a pass or a fail. A complete SOP references both.
A967 doesn't give you a number for that. How often you repassivate depends entirely on operating conditions. Pharmaceutical WFI systems running at 80°C typically need retreatment after derouging cycles. A lot of facilities schedule annual maintenance windows for this, often during the April shutdown period or right after monsoon season in October when corrosion checks are already on the calendar.